Medibank Private Crescita futura

Future criteri di controllo 4/6

Medibank Private prevede che gli utili e i ricavi cresceranno rispettivamente di 27.1% e 4.6% all'anno. Si prevede che l'EPS crescerà di 27.7% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 24.2% in 3 anni.

Informazioni chiave

27.1%

Tasso di crescita degli utili

27.7%

Tasso di crescita dell'EPS

Insurance crescita degli utili	7.4%
Tasso di crescita dei ricavi	4.6%
Rendimento futuro del capitale proprio	24.2%
Copertura analitica	Good
Ultimo aggiornamento	01 Nov 2024

Aggiornamenti recenti sulla crescita futura

Recent updates

We Discuss Whether Medibank Private Limited's (ASX:MPL) CEO Is Due For A Pay Rise

Nov 15

With EPS Growth And More, Medibank Private (ASX:MPL) Makes An Interesting Case

Nov 01

Medibank Private's (ASX:MPL) Shareholders Will Receive A Bigger Dividend Than Last Year

Sep 09

Medibank Private's (ASX:MPL) Upcoming Dividend Will Be Larger Than Last Year's

Aug 26

Medibank Private (ASX:MPL) Has Announced That It Will Be Increasing Its Dividend To A$0.073

Aug 21

Is Now The Time To Put Medibank Private (ASX:MPL) On Your Watchlist?

May 29

Medibank Private's (ASX:MPL) Shareholders Will Receive A Bigger Dividend Than Last Year

Feb 28

Does Medibank Private (ASX:MPL) Deserve A Spot On Your Watchlist?

Feb 27

Medibank Private's (ASX:MPL) Dividend Will Be Increased To AU$0.069

Aug 30

Are Dividend Investors Getting More Than They Bargained For With Medibank Private Limited's (ASX:MPL) Dividend?

Feb 14

Is Medibank Private Limited's (ASX:MPL) Recent Stock Performance Influenced By Its Financials In Any Way?

Jan 19

Did You Participate In Any Of Medibank Private's (ASX:MPL) Respectable 74% Return?

Dec 23

Previsioni di crescita degli utili e dei ricavi

ASX:MPL - Stime future degli analisti e dati finanziari passati (AUD Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
6/30/2027	9,335	642	646	724	4
6/30/2026	8,978	626	646	714	5
6/30/2025	8,595	591	665	675	5
6/30/2024	8,030	4	811	869	N/A
3/31/2024	7,939	89	N/A	N/A	N/A
12/31/2023	7,944	685	326	373	N/A
9/30/2023	7,720	598	234	279	N/A
6/30/2023	7,398	N/A	143	185	N/A
3/31/2023	7,261	171	N/A	N/A	N/A
12/31/2022	7,124	343	729	764	N/A
9/30/2022	7,114	368	821	856	N/A
6/30/2022	7,105	394	913	949	N/A
3/31/2022	7,117	414	693	728	N/A
12/31/2021	7,130	435	472	508	N/A
9/30/2021	7,081	438	460	495	N/A
6/30/2021	7,032	441	447	482	N/A
3/31/2021	6,930	402	547	579	N/A
12/31/2020	6,829	363	647	676	N/A
9/30/2020	6,804	340	595	624	N/A
6/30/2020	6,779	316	543	572	N/A
3/31/2020	6,836	368	451	486	N/A
12/31/2019	6,892	420	358	399	N/A
9/30/2019	6,829	429	362	408	N/A
6/30/2019	6,765	438	367	416	N/A
12/31/2018	6,381	375	332	377	N/A
9/30/2018	6,479	400	348	393	N/A
6/30/2018	6,577	424	365	408	N/A
3/31/2018	7,010	454	N/A	428	N/A
12/31/2017	7,006	463	N/A	448	N/A
9/30/2017	6,977	456	N/A	421	N/A
6/30/2017	6,948	450	N/A	393	N/A
3/31/2017	6,914	436	N/A	379	N/A
12/31/2016	6,879	422	N/A	365	N/A
9/30/2016	6,843	420	N/A	359	N/A
6/30/2016	6,807	418	N/A	352	N/A
3/31/2016	6,791	393	N/A	363	N/A
12/31/2015	6,774	369	N/A	374	N/A
9/30/2015	6,728	327	N/A	375	N/A
6/30/2015	6,682	285	N/A	377	N/A
3/31/2015	6,631	244	N/A	338	N/A
12/31/2014	6,581	204	N/A	298	N/A
9/30/2014	6,533	167	N/A	306	N/A
6/30/2014	6,486	131	N/A	313	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di MPL ( 27.1% all'anno) è superiore al tasso di risparmio ( 2.6% ).

Guadagni vs Mercato: Si prevede che gli utili di MPL ( 27.1% all'anno) cresceranno più rapidamente del mercato Australian ( 12.4% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di MPL cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Si prevede che il fatturato di MPL ( 4.6% all'anno) crescerà più lentamente rispetto al mercato Australian ( 5.6% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di MPL ( 4.6% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di MPL sarà elevato tra 3 anni ( 24.2 %)

Medibank Private Crescita futura

Future criteri di controllo 4/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Consensus EPS estimates increase by 11%

Price target decreased to AU$3.36

Consensus EPS estimates fall by 10%

Price target decreased to AU$3.45

Medibank Private Limited Provides Earnings Guidance for 2022

Recent updates

Medibank Private Limited, Annual General Meeting, Nov 13, 2024

Final dividend of AU$0.094 announced

Medibank Private Limited Announces Ordinary Fully Franked Dividend for the Six Months Ended June 30, 2024, Payable on September 26, 2024

Full year 2024 earnings: EPS misses analyst expectations

Is Now The Time To Put Medibank Private (ASX:MPL) On Your Watchlist?

Medibank Private Limited's (ASX:MPL) Prospects Need A Boost To Lift Shares

Here's Why Medibank Private (ASX:MPL) Has Caught The Eye Of Investors

High number of new directors

First half dividend increased to AU$0.072

New major risk - Revenue and earnings growth

First half 2024 earnings: EPS exceeds analyst expectations

Consensus EPS estimates increase by 11%

Medibank Private Limited (ASX:MPL) Investors Are Less Pessimistic Than Expected

Medibank Private Limited to Report First Half, 2024 Results on Feb 22, 2024

We Discuss Whether Medibank Private Limited's (ASX:MPL) CEO Is Due For A Pay Rise

With EPS Growth And More, Medibank Private (ASX:MPL) Makes An Interesting Case

Medibank Private Limited Announces Changes to Executive Leadership Team

Anna Bligh to Retire as Non-Executive Director of Medibank Private Limited At the Conclusion its Annual General Meeting on 22 November 2023

Medibank Private's (ASX:MPL) Shareholders Will Receive A Bigger Dividend Than Last Year

Upcoming dividend of AU$0.083 per share at 4.1% yield

Medibank Private's (ASX:MPL) Upcoming Dividend Will Be Larger Than Last Year's

Medibank Private Limited Fully Franked Final Ordinary Dividend for the Six Months Ended 30 June 2023, Payable on 5 October 2023

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Medibank Private Limited Announces Executive Changes, Effective 31 July 2023

Medibank Private Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

First half 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Medibank Announces Class Action Filed in the Federal Court of Australia

Medibank Private Limited to Report First Half, 2023 Results on Feb 23, 2023

Now 21% undervalued after recent price drop

Price target decreased to AU$3.36

Consensus EPS estimates fall by 10%

Price target decreased to AU$3.45

Investor sentiment deteriorated over the past week

Upcoming dividend of AU$0.073 per share

Medibank Private (ASX:MPL) Has Announced That It Will Be Increasing Its Dividend To A$0.073

Full year 2022 earnings: EPS and revenues miss analyst expectations

Medibank Private Limited Announces Distribution for the Six Months Ended June 30, 2022, Payable on September 29, 2022

Healius Reportedly Launches Day Surgery Sale Process

Is Now The Time To Put Medibank Private (ASX:MPL) On Your Watchlist?

Medibank Private Limited to Report Fiscal Year 2022 Results on Aug 18, 2022

Independent Non-Executive Director recently bought AU$151k worth of stock

Medibank Private's (ASX:MPL) Shareholders Will Receive A Bigger Dividend Than Last Year

Does Medibank Private (ASX:MPL) Deserve A Spot On Your Watchlist?

First half 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Medibank Private Limited Announces Ordinary Fully Paid Dividend for the Six Months Ended December 31, 2021, Payable on March 24, 2022

Medibank Private Limited Appoints Kathryn Fagg Ao and Peter Everingham as Non-Executive Directors Effective 31 March 2022

Now 22% undervalued after recent price drop

Upcoming dividend of AU$0.069 per share

Medibank Private's (ASX:MPL) Dividend Will Be Increased To AU$0.069

Medibank Private Limited Provides Earnings Guidance for 2022

Full year 2021 earnings released: EPS AU$0.16 (vs AU$0.12 in FY 2020)

CEO & Director Craig Drummond has left the company

First half 2021 earnings released: EPS AU$0.082 (vs AU$0.065 in 1H 2020)

Earnings beat expectations, revenue disappoints

Craig Drummond to Retire as Chief Executive Officer of Medibank Private Limited on 30 June 2021

New 90-day low: AU$2.79

Are Dividend Investors Getting More Than They Bargained For With Medibank Private Limited's (ASX:MPL) Dividend?

Medibank Private Limited (ASX:MPL) entered into share purchase agreement to acquire 49%stake in Myhealth Medical Holdings Pty Ltd from Crescent Capital Partners Management Pty Ltd and others for AUD 63 million.

Is Medibank Private Limited's (ASX:MPL) Recent Stock Performance Influenced By Its Financials In Any Way?

Did You Participate In Any Of Medibank Private's (ASX:MPL) Respectable 74% Return?

Medibank Private Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: AU$3.04

New 90-day high: AU$2.90

New 90-day low - AU$2.49

Independent Non-Executive Director recently bought AU$115k worth of stock

New 90-day low - AU$2.73

Earnings released

Previsioni di crescita degli utili e dei ricavi

Previsioni di crescita futura degli analisti

Previsioni di crescita dell'utile per azione